001 | 1007648 | ||
005 | 20250719052322.0 | ||
024 | 7 | _ | |a eva578704 |2 HSB |
024 | 7 | _ | |a 2152-2650 |2 ISSN |
024 | 7 | _ | |a 2152-2669 |2 ISSN |
024 | 7 | _ | |a SCOPUS:2-s2.0-85184267458 |2 SCOPUS |
024 | 7 | _ | |a WOS:001221080700001 |2 WOS |
024 | 7 | _ | |a 10.1016/j.clml.2024.01.005 |2 doi |
024 | 7 | _ | |a pmid:38278737 |2 pmid |
024 | 7 | _ | |a 10.18154/RWTH-CONV-254031 |2 datacite_doi |
037 | _ | _ | |a RWTH-CONV-254031 |
041 | _ | _ | |a English |
100 | 1 | _ | |a Kantarjian, Hagop M. |b 0 |e Corresponding author |
245 | _ | _ | |a A Review of the Therapeutic Role of Bosutinib in Chronic Myeloid Leukemia |h online |
260 | _ | _ | |c 2024 |
336 | 7 | _ | |0 0 |2 EndNote |a Journal Article |
336 | 7 | _ | |0 PUB:(DE-HGF)16 |2 PUB:(DE-HGF) |a Journal Article |b journal |m journal |
336 | 7 | _ | |2 BibTeX |a ARTICLE |
336 | 7 | _ | |2 DRIVER |a article |
336 | 7 | _ | |2 DataCite |a Output Types/Journal article |
336 | 7 | _ | |2 ORCID |a JOURNAL_ARTICLE |
591 | _ | _ | |a Canada |
591 | _ | _ | |a Germany |
591 | _ | _ | |a Italy |
591 | _ | _ | |a USA |
700 | 1 | _ | |a Jabbour, Elias J. |b 1 |
700 | 1 | _ | |a Lipton, Jeffrey H. |b 2 |
700 | 1 | _ | |a Castagnetti, Fausto |b 3 |
700 | 1 | _ | |0 P:(DE-82)IDM06025 |a Brümmendorf, Tim Henrik |b 4 |u rwth |
773 | _ | _ | |0 PERI:(DE-600)2540998-0 |a 10.1016/j.clml.2024.01.005 |n 5 |p 285-297 |t Clinical lymphoma, myeloma & leukemia |v 24 |x 2152-2650 |
856 | 4 | _ | |u https://publications.rwth-aachen.de/record/1007648/files/1007648.pdf |y OpenAccess |
909 | C | O | |o oai:publications.rwth-aachen.de:1007648 |p openaire |p open_access |p VDB |p driver |p dnbdelivery |
910 | 1 | _ | |0 I:(DE-588b)36225-6 |6 P:(DE-82)IDM06025 |a RWTH Aachen |b 4 |k RWTH |
914 | 1 | _ | |y 2024 |
915 | 1 | _ | |0 StatID:(DE-HGF)0031 |2 StatID |a Peer reviewed article |x 0 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2023-10-26 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2023-10-26 |
915 | _ | _ | |a Creative Commons Attribution CC BY 4.0 |0 LIC:(DE-HGF)CCBY4 |2 HGFVOC |
915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b CL LYMPH MYELOM LEUK : 2022 |d 2023-10-26 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2023-10-26 |
915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2023-10-26 |
915 | _ | _ | |a IF < 5 |0 StatID:(DE-HGF)9900 |2 StatID |d 2023-10-26 |
915 | _ | _ | |a OpenAccess |0 StatID:(DE-HGF)0510 |2 StatID |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2023-10-26 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1110 |2 StatID |b Current Contents - Clinical Medicine |d 2023-10-26 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2023-10-26 |
920 | 1 | _ | |0 I:(DE-82)531040-2_20140620 |k 531040-2 |l Klinik und Lehrstuhl für Innere Medizin (mit dem Schwerpunkt Onkologie und Hämatologie) |x 0 |
970 | _ | _ | |a eva578704 |
980 | _ | _ | |a I:(DE-82)531040-2_20140620 |
980 | _ | _ | |a UNRESTRICTED |
980 | _ | _ | |a VDB |
980 | _ | _ | |a journal |
980 | 1 | _ | |a FullTexts |
Library | Collection | CLSMajor | CLSMinor | Language | Author |
---|